Evolution of Pharmaceutical Expenditure and Cost Avoidance in Cancer Clinical Trials: A 10-Year Retrospective Study of Adult Solid Tumor Patients (Highlights longitudinal “evolution” in drug patterns alongside DCA.) | Publicación